SCHEMBL1968495

SCHEMBL1968495

O=[N+]([O-])N1C=CC=NC1Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18740720 0.76
SCHEMBL1600247 0.65
SCHEMBL28102807 0.60
SCHEMBL6850009 0.58
SCHEMBL4038269 0.58
SCHEMBL5281139 0.57
SCHEMBL7664408 0.55
SCHEMBL8837921 0.55
SCHEMBL2085606 0.50
SCHEMBL9679373 0.50

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107567443-A biaryl derivatives as GPR120 agonists 株式会社LG化学 2018-01-09 CN disclosed
CN-107021951-A SGC stimulators 铁木医药有限公司 2017-08-08 CN disclosed
EP-1881982-B1 IMIDAZOLONE PHENYLALANINE DERIVATIVES AS VLA-4 ANTAGONISTS ELAN PHARM INC (US) 2013-11-20 EP disclosed
US-8030328-B2 Imidazolone phenylalanine derivatives ELAN PHARMACEUTICALS, INC. (US) 2011-10-04 US disclosed
EP-2336133-A1 Purine analogs having HSP90-inhibiting activity Conforma Therapeutics Corporation (US) 2011-06-22 EP disclosed
CN-102060806-A Cytokine inhibitors ITHERX PHARMACEUTICALS INC 2011-05-18 CN disclosed
CN-101057306-B Electrolyte for electrolytic capacitor and electrolytic capacitor utilizing the same MATSUSHITA ELECTRIC INDUSTRIAL CO LTD 2010-09-08 CN disclosed
CN-101679426-A 9- (pyrazol-3-yl) -9H-purin-2-amine and 3- (pyrazol-3-yl) -3H-imidazo [4, 5-b ] pyridin-5-amine derivatives and their use to treat cancer ASTRAZENECA AB 2010-03-24 CN disclosed
CN-101505762-A Orally active purinyl inhibitors of heat shock protein 90 CONFORMA THERAPEUTICS CORP (US) 2009-08-12 CN disclosed
CN-101300255-A Imidazolone phenylalanine derivatives as VLA-4 antagonists ELAN PHARM INC (US) 2008-11-05 CN disclosed
US-7241890-B2 Purine analogs having HSP90-inhibiting activity CONFORMA THERAPEUTICS CORPORATION (US) 2007-07-10 US disclosed
WO-2007075572-A2 ORALLY ACTIVE PURINE-BASED INHIBITORS OF HEAT SHOCK PROTEIN 90 CONFORMA THERAPEUTICS CORPORATION (US) 2007-07-05 WO disclosed
US-20070129334-A1 Orally Active Purine-Based Inhibitors of Heat Shock Protein 90 CONFORMA THERAPEUTICS CORPORATION (US) 2007-06-07 US disclosed
US-20070037804-A1 Imidazolone phenylalanine derivatives TBD 2007-02-15 US disclosed
CN-1878769-A Cytokine inhibitors KEMIA INC (US) 2006-12-13 CN disclosed
WO-2006127584-A1 IMIDAZOLONE PHENYLALANINE DERIVATIVES AS VLA-4 ANTAGONISTS ELAN PHARMACEUTICALS, INC. (US) 2006-11-30 WO disclosed
US-20050049263-A1 Purine analogs having hsp90-inhibiting activity CONFORMA THERAPEUTICS CORPORATION 2005-03-03 US disclosed
EP-1440072-A4 PURINE ANALOGS HAVING HSP90-INHIBITING ACTIVITY CONFORMA THERAPEUTIC CORP (US) 2005-02-02 EP disclosed
EP-1440072-A2 PURINE ANALOGS HAVING HSP90-INHIBITING ACTIVITY Conforma Therapeutic Corporation (US) 2004-07-28 EP disclosed
WO-2003037860-A2 PURINE ANALOGS HAVING HSP90-INHIBITING ACTIVITY CONFORMA THERAPEUTICS CORPORATION (US) 2003-05-08 WO disclosed